Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections

Clinical Microbiology and Infection

Volumn 20, Issue 5, 2014, Pages

  Stevens, V ^a,b,c   Geiger, K ^c,d   Concannon, C ^b   Nelson, R E ^e,f   Brown, J ^b,c,g   Dumyati, G ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e Salt Lake Veterans Affairs Healthcare System   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g ST JOHN FISHER COLLEGE   (United States)

Author keywords

Central line associated bloodstream infection; Cost; Healthcare associated infections; In hospital mortality

Indexed keywords

ADULT; APACHE; ARTICLE; CATHETER INFECTION; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; COST OF ILLNESS; ECONOMIC EVALUATION; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL COST; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; AGED; BACTEREMIA; CENTRAL VENOUS CATHETER; CROSS INFECTION; ECONOMICS; FUNGEMIA; INTENSIVE CARE; MICROBIOLOGY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; APACHE; BACTEREMIA; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; CROSS INFECTION; FEMALE; FUNGEMIA; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84901589107     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12407     Document Type: Article

References (31)

1. Olaechea PM, Palomar M, Alvarez-Lerma F, Otal JJ, Insausti J, Lopez-Pueyo MJ. Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients. Rev Esp Quimioter 2013; 26: 21-29.
2. Scott RD II. The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention. Atlanta, GA: Centers for Disease Control and Prevention, 2009.
3. Department of Health and Human Services. Medicare Program; changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates, 2008. Available from: http://edocket.access.gpo.gov/2008/pdf/E8-17914.pdf (last accessed 8 October 2013).
4. Dudeck MA, Horan TC, Peterson KD et al. National healthcare safety network report, data summary for 2011, device-associated module. Am J Infect Control 2013; 41: 286-300.
5. Al-Rawajfah OM, Hewitt JB, Stetzer F, Cheema J. Length of stay and charges associated with health care-acquired bloodstream infections. Am J Infect Control 2012; 40: 227-232.
6. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-1601.
7. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 2006; 34: 2084-2089.
8. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160: 976-981.
9. Shannon RP, Patel B, Cummins D, Shannon AH, Ganguli G, Lu Y. Economics of central line-associated bloodstream infections. Am J Med Qual 2006; 21: 7S-16S.
10. Barnett AG, Graves N, Rosenthal VD, Salomao R, Rangel-Frausto MS. Excess length of stay due to central line-associated bloodstream infection in intensive care units in Argentina, Brazil, and Mexico. Infect Control Hosp Epidemiol 2010; 31: 1106-1114.
11. Roberts RR, Scott RD II, Hota B et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010; 48: 1026-1035.
12. Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Healthcare epidemiology: estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010; 50: 1017-1021.
13. Lukenbill J, Rybicki L, Sekeres MA et al. Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2013; 19: 720-724.
14. Hu B, Tao L, Rosenthal VD et al. Device-associated infection rates, device use, length of stay, and mortality in intensive care units of 4 Chinese hospitals: International Nosocomial Control Consortium findings. Am J Infect Control 2013; 41: 301-306.
15. National Healthcare Safety Network: central line associated bloodstream infection event. Atlanta, GA, 2013. Available from: http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf. (last accessed 8 October 2013).
16. Riewpaiboon A, Malaroje S, Kongsawatt S. Effect of costing methods on unit cost of hospital medical services. Trop Med Int Health 2007; 12: 554-563.
17. Bureau of Economic Analysis: personal consumption expenditures. Bureau of Economic Analysis. Available from: http://www.bea.gov/iTable/iTable.cfm?ReqID=12&step=1&acrdn=2#reqid=12&step=1&isuri=1 (last accessed 1 July 2013).
18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
20. Stevens V, Lodise TP, Tsuji B et al. The utility of Acute Physiology and Chronic Health Evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2012; 33: 558-564.
21. Muldoon JH. Structure and performance of different drug classification systems for neonatal medicine. Pediatrics 1999; 103: 302-318.
22. Healthcare Utilization Project: procedure classes, 2013. Available from: http://www.hcup-us.ahrq.gov/toolssoftware/procedure/procedure.jsp (last accessed 8 October 2013).
23. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005; 24: 465-488.
24. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001; 20: 461-494.
25. Allison PD. Logistic regression using SAS(R): theory and application, 2nd edn. Cary, NC: SAS(R) Publishing, 2012.
26. Srinivasan A, Wise M, Bell M et al. Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR 2011; 60: 243-248.
27. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003; 54: 258-266.
28. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32: 101-114.
29. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001; 136: 229-234.
30. Graves NP, Barnett AGP, Halton KP et al. The importance of good data, analysis, and interpretation for showing the economics of reducing healthcare-associated infection. Infect Control Hosp Epidemiol 2011; 32: 927-928.
31. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011; 14: 381-386.